Prognostic models in bipolar disorder: can the prediction of the long-term clinical course rely on the integration of clinical and molecular data?
Servizio Psichiatrico di Diagnosi e Cura, Dipartimento di Salute Mentale, Ospedale San Martino, Oristano, Italy.
Martina
M
Pinna
Mirko
M
Manchia
D018692:Antimanic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D011379:Prognosis
D018692:Antimanic Agents; D015415:Biomarkers; D008094:Lithium; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3